Cardiorespiratory Fitness and Incidence of Type 2 Diabetes in United States Veterans on Statin Therapy.

[1]  S. Blair,et al.  A call to increase physical activity across the globe in the 21st century. , 2016, Future cardiology.

[2]  W. Xia,et al.  Statins worsen glycemic control of T2DM in target LDL-c level and LDL-c reduction dependent manners: a meta-analysis , 2016, Expert opinion on pharmacotherapy.

[3]  P. Thompson,et al.  Statin-Associated Side Effects. , 2016, Journal of the American College of Cardiology.

[4]  Paul T. Williams,et al.  Effects of Statin Therapy on Exercise Levels in Participants in the National Runners' and Walkers' Health Study. , 2015, Mayo Clinic proceedings.

[5]  B. Franklin,et al.  Impact of Statins on Physical Activity and Fitness: Ally or Adversary? , 2015, Mayo Clinic proceedings.

[6]  Ross Arena,et al.  Exercise and the cardiovascular system: clinical science and cardiovascular outcomes. , 2015, Circulation research.

[7]  X. Sui,et al.  Exercise capacity and risk of chronic kidney disease in US veterans: a cohort study. , 2015, Mayo Clinic proceedings.

[8]  Hynek Pikhart,et al.  HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.

[9]  P. Kokkinos,et al.  Cardiorespiratory fitness, exercise, and blood pressure. , 2014, Hypertension.

[10]  Susan T. Shero,et al.  2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[11]  Michael J Pencina,et al.  Application of new cholesterol guidelines to a population-based sample. , 2014, The New England journal of medicine.

[12]  S. Blair,et al.  Physical activity promotion in the health care system. , 2013, Mayo Clinic proceedings.

[13]  P. Fadel,et al.  Simvastatin impairs exercise training adaptations. , 2013, Journal of the American College of Cardiology.

[14]  D. Panagiotakos,et al.  Statins modulate the mortality risk associated with obesity and cardiorespiratory fitness in diabetics. , 2013, The Journal of clinical endocrinology and metabolism.

[15]  Tara Gomes,et al.  Risk of incident diabetes among patients treated with statins: population based study , 2013, BMJ.

[16]  D. Panagiotakos,et al.  Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study , 2013, The Lancet.

[17]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[18]  Masanori Tamaki,et al.  Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance. , 2012, Journal of applied physiology.

[19]  D. Panagiotakos,et al.  Exercise Capacity and Progression From Prehypertension to Hypertension , 2012, Hypertension.

[20]  M. Quon,et al.  Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy. , 2012, Atherosclerosis.

[21]  Paul Welsh,et al.  Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. , 2011, JAMA.

[22]  J. Myers,et al.  Exercise and physical activity: clinical outcomes and applications. , 2010, Circulation.

[23]  Demosthenes B Panagiotakos,et al.  Exercise capacity and mortality in older men: a 20-year follow-up study. , 2010, Circulation.

[24]  M. Quon,et al.  Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. , 2010, Journal of the American College of Cardiology.

[25]  Yasuo Ohashi,et al.  Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials , 2010, The Lancet.

[26]  D. Panagiotakos,et al.  Exercise Capacity and All-Cause Mortality in African American and Caucasian Men With Type 2 Diabetes , 2009, Diabetes Care.

[27]  S. Blair,et al.  Associations of Cardiorespiratory Fitness and Obesity With Risks of Impaired Fasting Glucose and Type 2 Diabetes in Men , 2009, Diabetes Care.

[28]  J. Myers,et al.  Exercise Capacity and Mortality in Black and White Men , 2008, Circulation.

[29]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[30]  Donald R. Miller,et al.  No racial differences in mortality found among Veterans Health Administration out-patients. , 2004, Journal of clinical epidemiology.

[31]  D. Berlowitz,et al.  Risk-Adjusted Mortality Rates as a Potential Outcome Indicator for Outpatient Quality Assessments , 2002, Medical care.

[32]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[33]  J. Feussner,et al.  Reinventing VA health care: systematizing quality improvement and quality innovation. , 2000, Medical care.

[34]  V. Froelicher,et al.  Comparison of the ramp versus standard exercise protocols. , 1991, Journal of the American College of Cardiology.

[35]  Paul McAuley,et al.  Physical activity and cardiorespiratory fitness as major markers of cardiovascular risk: their independent and interwoven importance to health status. , 2015, Progress in cardiovascular diseases.

[36]  R. Ross,et al.  Strategies for promoting physical activity in clinical practice. , 2015, Progress in cardiovascular diseases.